Market Research Report

Animal Biotechnology - Technologies, Markets and Companies

cover Published by Jain Pharmabiotech
Published Product code 70922
Price

Introduction

Abstract

Summary

This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture

Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine

Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.

Biotechnology products are approved by the Center for Veterinary Medicine of the FDA. Regulatory issues relevant to animal biotechnology are described.

Approximately 111 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 108 collaborations in this area are shown.

Share of biotechnology-based products and services in 2012 is analyzed and the market is projected to 2022.

The text is supplemented with 34 tables and 5 figures.Selected 250 references from the literature are appended.

Table of Contents

Table of Contents

0. Executive Summary 12

1. Introduction to Animal Biotechnology 14

  • Introduction 14
  • Historical evolution of animal biotechnology 14
  • Basics of biotechnology 15
  • DNA 15
  • RNA 15
  • Genes 16
  • Single nucleotide polymorphisms 16
  • Copy number variations in the genome 16
  • DNA sequences 17
  • Gene expression 17
  • Gene regulation 18
  • Proteins 18
  • Functions of proteins 18
  • Recombinant proteins 19
  • Monoclonal antibodies 20
  • Animal genetics 20
  • Molecular genetics 20
  • Twinning in cattle 21
  • Pig genetics 21
  • Genetic studies in dogs 21
  • Animal genomics 21
  • The mouse genome 21
  • The dog genome 22
  • Sequencing of the dog genome 22
  • Comparison of genomes of healthy and diseased dogs 24
  • Analysis of DNA copy number variation 24
  • The cat genome 25
  • Marsupial genomes 25
  • Genomes of non-human primates 25
  • Chimpanzee genome 25
  • Genome of the rhesus macaque 26
  • Genome of gorilla 26
  • Livestock genomics 27
  • Bovine genome 28
  • Bovine SNP map 28
  • Bovine stomach microbiome genes 29
  • Camel genome 30
  • Goat genome 30
  • Horse genome 31
  • Pig genome 31
  • Sheep genome 33
  • Chicken genome 33
  • Turkey genome 34
  • Salmon genome 35
  • Priority genome list of the National Human Genome Research Institute 35
  • Animal proteomics 36
  • Applications of proteomics in animals 36
  • Caseins in goat milk 37
  • Lactic acid bacteria 37
  • Applications of proteomics in animal healthcare 37
  • Antigenomics 37
  • Bioinformatics 38
  • Nanobiotechnology and animal health 39
  • Biomarkers and animal health 39
  • Recombinant protein manufacture 40
  • Animal biotechnology in relation to other technologies 40

2. Application of Biotechnology in Animals 42

  • Introduction 42
  • Applications of animal genomics 42
  • Bovine ankyrin 1 gene and beef tenderness 42
  • Chicken breeding based on genomics 43
  • Genomics of disease resistance 43
  • Genome wide associations and milk production in cows 43
  • Low cost genotyping for genetic improvement in dairy cattle 44
  • SNPs and longevity in dairy cattle 44
  • Share genomic data to improve cattle breeding programs 44
  • Statistical genomics to improve breeding 44
  • Genetic engineering 45
  • Livestock improvement by genetic engineering 45
  • Disease control by genetic engineering 45
  • Limitations and precautions for genetic engineering 45
  • Transgenic animal technology 46
  • Cloning animals 47
  • Nuclear transfer technology 47
  • Nuclear bisection for cloning 49
  • Zona-free cloning method 49
  • Abnormalities in cloned animals 50
  • Cloning from embyonic cells 51
  • Cloning of rabbits 51
  • Cloning the rat 52
  • Cloning the horse 52
  • Cloning the cow 52
  • Cloning the dog 53
  • Cloning in primates 53
  • Retrovector-mediated production of transgenic animals 53
  • Episomal vector-mediated gene delivery 54
  • Sperm-mediated gene transfer 54
  • Lentiviral transduction of male germ-line stem cells 55
  • Lentiviral transgenesis 56
  • Transgenic pharmaceuticals 56
  • Proteins from the milk of transgenic animals 56
  • Advantages of milk as source of transgenic proteins 57
  • Therapeutic proteins from rabbit milk 58
  • Recombinant human antibodies from cows 59
  • Therapeutic proteins from goat milk 59
  • Chicken transgenesis for the production of biopharmaceuticals 60
  • Concluding remarks about production of recombinant proteins in animals 60
  • Companies involved in production of transgenic pharmaceuticals 60
  • Transgenic food products 61
  • Milking genetically modified cows 61
  • Transgenic fish 61
  • Cloned animals as sources of milk and meat 62
  • Animal feeds from transgenic plants 62
  • Transgenic modification of plants to increase nutritional value of animal feeds 63
  • Transgenic disease models 63
  • Technologies to create transgenic disease models 63
  • Gene manipulation techniques 63
  • Embryonic stem cells for gene targeting 64
  • Homologous recombination 64
  • Animal models of human diseases 65
  • Transgenic models for studying human drug metabolism and toxicity 65
  • The Human Genome Project and the role of transgenics 66
  • Genomic and proteomic analyses of transgenic animal models 66
  • Concern about health and welfare of transgenic animals 67
  • Safety of transgenic technology 67
  • Concluding remarks about use of transgenic animals 68
  • RNA interference technology 68
  • RNAi versus antisense 68
  • Applications of RNAi in animal biotechnology 68
  • Xenotransplantation 69
  • Pigs for xenotransplantation 69
  • Genetically engineered pigs for transplants 70
  • Risks of xenotransplantation 70
  • World Health Organization and xenotransplantation 71
  • Ethical aspects of animal biotechnology 71

3. A Biotechnology Perspective of Animals Diseases 74

  • Introduction 74
  • Infections in animals 74
  • Viral infections 75
  • Avian influenza 75
  • Animal surveillance of influenza 77
  • Animal biotechnology implications of H1N1 influenza 78
  • Animal corona viruses and human SARS 79
  • Avian coronavirus 79
  • Bluetongue virus 80
  • Canine parvovirus 80
  • Classical swine fever 80
  • Developing new treatments against FMD 80
  • Equine infectious anemia 81
  • Foot-and-mouth disease 82
  • Porcine reproductive and respiratory syndrome virus 83
  • Rabies 84
  • Rinderpest 84
  • Schmallenberg virus 84
  • Bacterial infections 85
  • Bovine tuberculosis 85
  • Mycoplasmal pneumonia 86
  • Fungal infections 86
  • Protozoal infections 86
  • Coccidiosis 86
  • Neosporosis 87
  • Toxoplasmosis 87
  • Trypanosomiasis 87
  • Nematodes 88
  • Infections that cross the species barrier 88
  • Complications of bacterial infections and antibiotic use in animals 88
  • Transmissible spongiform encephalopathies (TSEs) 89
  • Inter-species transfer of prions 89
  • Scrapie 90
  • Bovine spongiform encephalopathy 90
  • Epidemiology of BSE 90
  • Biomarkers in the urine of BSE infected cattle 91
  • Human health implications of BSE 92
  • Breeding animals protected against BSE 92
  • TSE research 92
  • Prion gene haplotyping 92
  • Pharmacological approaches to TSE research 93
  • Molecular diagnostic approach to TSE research 93
  • RNAi for knockdown of the bovine prion gene 94
  • Chronic wasting disease 94
  • Chronic wasting disease in wildlife 94
  • Chronic wasting disease of the cattle in Sudan 95
  • Chronic wasting in dairy cows in the Netherlands 95
  • Genetic disorders in farm animals 96
  • Genetic predisposition to acquired diseases in animals 96
  • Diseases of pet animals 96
  • Canine anemia 96
  • Canine epilepsy 97
  • Cardiovascular disease 97
  • Heart failure 97
  • Cardiac complications of canine babesiosis 98
  • Diabetes 98
  • Role of biotechnology in management of diabetes 98
  • Arthritis 99
  • Cancer in cats and dogs 99
  • Cancer clinical trials in dogs 100
  • Canine Comparative Oncology Genomics Consortium 100
  • Preventive veterinary medicine 101
  • Prevention of introduction of foreign animal diseases 101
  • Producing transgenic cattle resistant to BSE 101
  • Zoonotic diseases 102
  • Global impact of zoonotic diseases 102
  • Viruses that emerge in animals and spread to humans 102
  • Collaborative management of animal and human health 103
  • Vaccines for zoonotic viral diseases 103

4. Molecular Diagnostics in Animals 104

  • Introduction 104
  • Nucleic acid technologies 104
  • The polymerase chain reaction 104
  • Basic Principles of PCR 104
  • Target selection 105
  • Detection of amplified DNA 105
  • Real-time PCR systems 105
  • LightCycler PCR system 106
  • Molecular beacons 106
  • Applications of PCR in veterinary medicine 106
  • Fluorescent in situ hybridization 107
  • Immunodiagnostics 109
  • Enzyme-linked immunoassays 109
  • Bovine Gamma Interferon Test 109
  • Antigen diagnosis of trichinosis 110
  • Parachek™ for the diagnosis of Johne's disease 110
  • Antibodies for differentiation between vaccinated and infected animals 111
  • Biochip/microarray technology 111
  • Applications of microarrays in animal biotechnology 112
  • Cattlearray3800 for functional genomics 112
  • eSensor™ electrochemical biochip 113
  • FR 48 microfluidic biochip 113
  • Biosensors 113
  • Immunosensors 114
  • Biosensor for ovulation prediction in dairy cows 114
  • Flow cytometry for animal diagnostics 115
  • Molecular imaging in animals 115
  • Veterinary cytogenetics 116
  • Applications of sequencing for veterinary diagnostics 117
  • Role of sequencing in detection of cancer biomarkers 117
  • DNA sequencing for study of bacterial epidemics 117
  • Role of sequencing in epidemic of Shiga toxin-producing E. coli 118
  • Role of sequencing in the study of genetic disorders in animals 118
  • Applications of molecular diagnostics in animals 119
  • Canine DNA testing 119
  • Cat pedigree determined by gene tests 119
  • Diagnostic aids to selective breeding 120
  • Selection of desirable traits 120
  • Gene variations and fat content of beef 121
  • Using genetic markers for improved milk production in dairy cattle 121
  • Application of bovine genomics for improving milk yield 121
  • Recognition of hereditary syndromes 122
  • Genetic markers in animals 122
  • SNP genotyping in animals 122
  • SNP genotyping for selective breeding of chicken 122
  • Animal identity and parentage analysis 123
  • Animal species identification in food 123
  • Diagnosis of infections 124
  • Bacterial infections 124
  • Diagnosis of fungal infections in animals 124
  • Diagnosis of viral infections 125
  • Molecular diagnosis of avian influenza 127
  • Molecular diagnosis of swine influenza 128
  • Diagnosis of parasitic infections 128
  • Detection of natural or bioterror threats to livestock 129
  • Molecular diagnosis of prion diseases 129
  • Bovine spongiform encephalopathy 129
  • Testing for BSE in living animals 131
  • Prions in urine 131
  • Diagnosis of chronic wasting disease in wildlife 132
  • Developing new tests for prion diseases 132
  • Differentiation among various types of TSEs 132
  • Protein cyclic amplification 132
  • Antibody tests for prion diseases 133
  • Scrapie genotyping 133
  • A real-time ultrasonic method for prion protein detection 134
  • Companies involved in developing molecular diagnostics for TSEs 134
  • Diagnosis of genetic disorders 135
  • Genetic screening of companion animals 135
  • Genes associated with exercise-induced collapse 135
  • Preimplantation genetic diagnosis 135
  • Diagnosis of cancer in animals 136
  • Diagnosis of skin cancer 136
  • Diagnosis of food-borne pathogens 136
  • Introduction 136
  • Molecular diagnostic methods used in food-borne infections 137
  • Detection of Listeria-contaminated foods 138
  • Optical biosensor for detection of Listeria 138
  • Real-time PCR for detection of Listeria 138
  • Detection of Salmonella 138
  • MicroSEQ® Salmonella Detection Kit 139
  • E. Coli detection 139
  • DuPont Bax system 139
  • MLG method for detection of multiple STEC strains 139
  • MicroSEQ® E. Coli Detection Kit 140
  • RapidFinder™ STEC 140
  • Limitations of use of molecular probes in food analysis 140
  • Companies with technologies for food pathogen detection 141
  • Biotechnology-based novel diagnostics for aquatic animals 142
  • Detection of chemicals in foods of animal origin 142
  • Companies developing molecular diagnostics for animals 143

5. Biotechnology-based Veterinary Medicine 144

  • Introduction 144
  • Biotechnology versus pharmaceutical products 144
  • Role of biotechnology in drug discovery and development 145
  • Cost of veterinary vs. human drug discovery and development 145
  • Advantages and disadvantages of testing biotech products in animal models 146
  • Biotechnolgoy-based antiparasitic drugs 146
  • Non-antibiotic strategies for control of infections in animals 146
  • Probiotics 147
  • Potential role for probiotics in the human gut 147
  • Potential role for probiotics in animals 147
  • Probiotic bacteria for control of pathogens in cattle 147
  • Nonantibiotic drugs for infections in animals 148
  • Immunomodulation as an alternative to antibiotics in infections 149
  • Cathelicidins: effector molecules of mammalian innate immunity 149
  • Bacteriophage therapy for antibiotic resistance 149
  • Biotechnology for treating tendon injuries 150
  • Use of growth factors to facilitate tendon injuries 150
  • Productivity enhancers 150
  • Bovine somatotropin for increasing milk production in dairy cows 151
  • Increasing milk production in cows by feeding propionibacteria 152
  • Use of growth factors 152
  • Transgenic plant products for use in animals 152
  • Biotechnology-based vaccines 153
  • Modern vaccines without viral non-structural proteins 153
  • Plant-derived vaccines for use in animals 154
  • Nano-bead vaccine adjuvant 155
  • Genetically engineered vaccines 155
  • Application of nucleic acid vaccines in veterinary medicine 155
  • DNA vaccines 155
  • DNA vaccine for tuberculosis 157
  • DNA vaccines for West Nile encephalitis 158
  • DNA vaccines for cancer 158
  • Gene-based vaccine for Marek's disease 159
  • Genetic engineering of live rabies vaccines 159
  • Genetically engineered vaccines for equine encephalitis 159
  • Genetically engineered vaccines for Johne's disease 160
  • Rational engineering of virus capsids to produce FMD vaccine 160
  • Vaccines against avian influenza 161
  • Vaccines against parasitic infections 162
  • Recombinant marker vaccines 162
  • Marker vaccines for foot-and-mouth disease 162
  • Marker vaccine for Newcastle disease 163
  • Vaccines for classical swine fever 163
  • Vaccines for tick control 163
  • Vaccination to protection swine from H1N1 influenza virus infection 164
  • Vaccination of cattle to prevent E. coli transmission to consumers in meat 164
  • Vaccines for bacterial equine respiratory infections 165
  • Using RNAi to develop vaccines for viral infections in prawns 165
  • Companies developing biotechnology-based vaccines 165
  • Biotechnology in treatment of parasitic infections 166
  • Biotechnology in the treatment of CNS injuries in pet animals 166
  • Paraplegia due to acute spinal cord injury in dogs 167
  • RNAi for suppression prions in livestock 167
  • Cell Therapy 168
  • Umbilical cord blood stem cells 168
  • Application of stem cells in veterinary medicine 168
  • Use of stem cells to repair tendon injuries in horses 168
  • Stem cells for spinal cord injury in dogs 169
  • Gene therapy 169
  • Gene therapy vectors 170
  • Gene therapy by mitochondrial transfer 170
  • In utero gene therapy 171
  • Applications of gene therapy in veterinary medicine 171
  • Gene therapy for arthritis 171
  • Gene therapy for blindness in dogs due to Leber congenital amaurosis 172
  • Gene therapy for cardiomyopathy in dogs 172
  • Gene therapy for diabetes in dogs 172
  • Gene therapy for endocrine disorders 173
  • Gene therapy for hematological disorders 173
  • Gene therapy for inherited disorders of metabolism in dogs 174
  • Gene therapy to increase disease resistance 175
  • Gene therapy for infections 175
  • Gene therapy for renal failure 175
  • Cancer gene therapy 176
  • Antiangiogeneic cancer gene therapy in dogs 176
  • Brain tumors in cats and dogs 176
  • Breast cancer in dogs 177
  • Canine hemangiosarcoma 178
  • Canine melanoma 178
  • Canine soft tissue sarcoma 179
  • Melanoma in horses 179
  • Oncolytic virotherapy for cancer in dogs 179

6. Research in Animal Biotechnology 182

  • Introduction 182
  • Research institutes 182
  • Ethical issues of research in animal biotechnology 190
  • Future prospects 191
  • Strategies for control of twining in cattle 191
  • Future developments of molecular diagnostics 191
  • Future of vaccine application in veterinary medicine 192
  • Promotion of innate immunity in animals 192
  • Identification of key parasite antigens for eliciting immune response 192
  • Virus-like particle vaccines for lasting immune response 193
  • Control of respiratory virus infections 193
  • Control and prevention of bioterrorism diseases in animals 193
  • Genetic control of disease resistance 194
  • Production of cattle lacking prion protein 194
  • Application of genetics and biotechnology to wildlife management 194
  • Future of animal genomics 195
  • Future prospects of in vitro meat production 195

7. Animal Biotechnology Markets 198

  • Introduction 198
  • Markets for biotechnology-based products for animal healthcare 199
  • Markets for biopharmaceuticals for animals 200
  • Markets for recombinant proteins for animal healthcare 200
  • Markets for vaccines for animals 201
  • Markets for animal diagnostics 201
  • Test for bovine spongiform encephalopathy 201
  • Animal biotechnology markets according to therapeutic areas 202
  • Markets for biotechnology-based animal products for humans 202
  • Transgenic proteins 204
  • Market for xenotransplantation 204
  • Strategies for promoting use of animal biotechnology 205
  • Financial losses from death and disease in animals 205
  • Losses in farm animals 205
  • Losses in poultry 205
  • Losses in equine industry 205
  • The emerging role of pet owners 205
  • Improvement in cattle through application of biotechnology 206
  • Economic aspects of genomic evaluation of dairy cattle 206
  • Pig market 206
  • Cattle Market 207
  • Poultry market 207
  • Milk from genetically modified cows 207
  • Transgenic fish 208
  • Role of biotechnology in livestock performace enhancer market 208
  • Gene transfer technologies 208
  • In vitro meat production and animal biotechnology markets 208
  • Cost-benefit aspects of transgenic proteins 208
  • Lower costs of transgenic production 208
  • Lower costs of treatment 209
  • Unmet needs in animal biotechnology 209
  • Future prospects of animal biotechnology 210
  • Farm animals 210
  • Global trends in epidemiology of livestock diseases 211
  • Genetic engineering of animals 211
  • Companion animals 211
  • Animal molecular diagnostic markets 212

8. Regulatory issues 214

  • Introduction 214
  • Regulatory agencies for veterinary biotechnology in the US 214
  • FDA regulatory issues in agricultural biotechnology 215
  • FDA guidlines on use of antibiotics in food-producing animals 216
  • FDA and veterinary stem cell therapy 217
  • Food safety evaluation of transgenic animals 218
  • Food from cloned animals 219
  • FDA investigation of drug transfer into eggs 220
  • Animal feed safety 221
  • Medicated feeds 222
  • Regulatory issues for production of transgenic proteins 222
  • Risks of animal biotechnology 222
  • FDA regulation of bovine products 223
  • Worldwide biotechnology regulatory and trade issues 223

9. Companies Involved in Animal Biotechnology 226

  • Introduction 226
  • Biotechnology at top veterinary pharmaceutical companies 226
  • Profiles of selected companies 226
  • Collaborations 349

10. References 354

Tables

  • Table 1-1: Landmarks in the evolution of animal biotechnology in the 20th century 14
  • Table 1-2: Expression systems for production of recombinant proteins 19
  • Table 1-3: Applications of proteomics in livestock industry and veterinary medicine 36
  • Table 1-4: Selected animal genomics and proteomics databases (DB) 38
  • Table 2-1: Applications of genomics in livestock industry and veterinary medicine 42
  • Table 2-2: Recombinant proteins obtained from milk of transgenic animals 58
  • Table 2-3: Companies involved in the production of transgenic pharmaceuticals 61
  • Table 2-4: A comparison of gene knockout and transgenic techniques 64
  • Table 2-5: Examples of transgenic mouse models of non-neoplastic human diseases 65
  • Table 3-1: Diseases of dairy cattle 74
  • Table 3-2: Causes of chronic wasting disease in animals 94
  • Table 4-1: Applications of microarrays in animal biotechnology 112
  • Table 4-2: Biosensor technologies with potential applications in molecular diagnostics 114
  • Table 4-3: Applications of molecular diagnostics in animals 119
  • Table 4-4: Viruses that can be detected by molecular diagnostics 125
  • Table 4-5: Testing for harmful prions in brain tissue from dead cattle 130
  • Table 4-6: Companies involved in developing molecular diagnostics for TSEs 134
  • Table 4-7: Pathogenic bacteria in food and targets for molecular diagnostic probes 137
  • Table 4-8: Companies involved in molecular diagnostics for food-borne infections 141
  • Table 4-9: Companies developing molecular diagnostics for veterinary medicine 143
  • Table 5-1: Veterinary biotechnology products 144
  • Table 5-2: Pharmaceutical versus biotechnology products 145
  • Table 5-3: Nonantibiotic strategies for control of infections 146
  • Table 5-4: Experimental DNA vaccines tested in animals 156
  • Table 5-5: Companies developing biotechnology-based vaccines for animals 165
  • Table 6-1: Areas for future research applications of animal biotechnologies 191
  • Table 7-1: Worldwide markets for biotechnology-based products for farm animals: 2012-2022 199
  • Table 7-2: Worldwide markets for biotechnology-based products for pet animals: 2012-2022 199
  • Table 7-3: Biotechnology-based markets for animal healthcare according to regions: 2012-2022 200
  • Table 7-4: Biotechnology markets for farm animals according to therapeutic areas: 2012-2022 202
  • Table 7-5: Biotechnology markets for pet animals in therapeutic areas: 2012-2022 202
  • Table 7-6: Worldwide markets for biotechnology-based animal products for humans: 2012-2022 204
  • Table 9-1: Ranking of top 7 veterinary companies with biotechnology products 226
  • Table 9-2: Selected collaborations of companies in animal biotechnology 349

Figures

  • Figure 1-1: Relation of animal biotechnology to other technologies and human health 40
  • Figure 2-1: Nuclear transfer technology 47
  • Figure 2-2: Generation of transgenic animals by linker based sperm-mediated gene transfer 55
  • Figure 2-3: Production of therapeutic proteins in the milk of transgenic animals 57
  • Figure 7-1: Unmet needs in animal biotechnology 210

Animal Biotechnology - Technologies, Markets and Companies published by Jain Pharmabiotech in April 1, 2013. This report price starts from US $ 3000.

The contents of this page may be different from the latest version. Please contact us for details.

Back to Top